This podcast discusses the recent judgement by the Delhi High Court to restrain Best Crop Science LLP and NATCO Pharma Ltd. from launching Chlorantraniliprole (‘CTPR’). The court has declined permission to manufacture and sell CTPR during the pendency of the suit.

Audio Source: An article published on LKS website in October 2021 https://www.lakshmisri.com/insights/articles/patents-delhi-high-court-rules-on-disclosure-vis-a-vis-invalidity-on-ground-of-obviousness/#

Authors:  Malathi Lakshmikumaran, Executive Director (LKS), and Archana Viswanathan, Principal Associate (LKS)

Voice: Gunmeher Juneja, Principal Associate (LKS)

www.lakshmisri.com